Our commitment to excellence
The EPO is now fully certified under the ISO standards for management systems pertaining to quality (ISO 9001); information security (ISO 27001); and occupational health and safety (ISO 45001). This reflects our total commitment to providing users of the patent system with the highest quality of products and services, as well as to creating the optimal working environment for our employees and achieving operational excellence.
Recent ISO audits formally recognised that we have implemented a range of best practices in line with international standards. As a result, the scope of ISO 9001 on quality management, which has covered the patent granting process since 2014, has been extended to the entire EPO's quality management system. And for the first time, certification of our information security management system (ISO 27001) was achieved. The audits also led to the maintenance of certification first obtained two years ago for our occupational health and safety management system (ISO 45001).
Certification is certainly not the end of the story, but another landmark in an ongoing journey of continuous improvement, where we enhance the value of the products and services we deliver to users. The renewal of our certification in the years to come will firmly reflect our sustained commitment to excellence.
Further information
Related items
Exchange on quality initiatives, the Unitary Patent, Observatory and strategic foresight activities
Exchanges on quality, the Unitary Patent, supplementary protection certificates, and the latest Guidelines for Examination
Exchanges on quality, the Unitary Patent and Standard Essential Patents
Preview versions of the EPC, PCT-EPO and UP Guidelines 2026 are published as of today. Our annual user consultation is now open for your feedback.
Plan and KPI dashboard provide transparency on actions and objectives
130 meetings held with increasingly diverse range of applicants and user associations, driving continuous improvement in products and services
Exchanges on Unitary Patent, technology trends and practice harmonisation
EPO and AIPPI met in Munich to discuss quality, digital transformation, the Unitary Patent and priorities for 2026
Discussions focused on quality, legal certainty and innovation in the biopharmaceutical industry
Discussions at annual meeting focus on shared priorities in quality, digital transformation and legal developments
Around 100 external stakeholders and EPO experts assess impact of the EPO’s Quality Action Plan 2025, AI tools and the Unitary Patent
Exchanges on quality, AI in the patent process and sustainable technologies
Strengthening collaboration with the Japan Patent Attorneys Association
High-level meetings held with ministers, national offices and users in Germany, the UK and Italy
Latest EPO audit figures confirm positive trend in quality indicators
Constructive exchanges on transparency, examination practices and quality plans
Exchanges on patent quality, plus impact of the Unitary Patent system and AI
Launching dialogue with the generics and biosimilars industry association